Ind-Swift Laboratories Limited Stock: price and insider trades · India
Ind-Swift Laboratories Limited: what insiders have been doing
Every trade that managers of Ind-Swift Laboratories Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. From 27 October 2025 to 27 October 2026, the disclosure feed for Ind-Swift Laboratories Limited logged 1 filing by 1 insider.
Only sales appear on the open market, 1 sale in all totalling €23k, filed by 1 insider. The largest single trade was a sale of €23k by Pardeep Verma, published on 28 September 2026.
For context, the typical company on the same exchange (median of 1,893 companies) published 4 filings over the same period, against 1 filing here. Our records for Ind-Swift Laboratories Limited go back to 2021, with no purchases and 13 sales on the open market in total.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 6,140 shares@ ₹408.80100.0% of flowEquityMarket SaleSEBI:c5abe12372f4499838a5164cb9fc5874c89a0974
- 30,000 shares@ ₹141.4076100.0% of flowEquity SharesSEBI:a27ccd696effb1c1a5622f1bea3af4402d176ea7
- 38,500 shares@ ₹86.2254100.0% of flowEquity SharesSEBI:0eb7c71c38964cc993ef8d1027b227050bbf1b0c
- 25,800 shares@ ₹72.8062100.0% of flowEquity SharesSEBI:8886ade41eb6fa1ae61fd824fc23f79430b8deff
- 14,799 shares@ ₹72.1472100.0% of flowEquity SharesSEBI:9e28c064d279c191b42118f406fdd2cba5265192
- 15,000 shares@ ₹72.0040.8% of flowEquity SharesSEBI:39ad4af52679d7364b6ed8533db619839e13e504
- 21,940 shares@ ₹71.412659.2% of flowEquity SharesSEBI:3ed11f7a61112ec25da9f30885c659c7e72447f2
- 58,792 shares@ ₹55.5007100.0% of flowEquity SharesSEBI:dbeda8a5e32f61ef473fe64ed45df6c41966a72b
- 15,000 shares@ ₹64.0024.4% of flowEquity SharesSEBI:771f2dfd03ccfe7057be42f386bf47c12a4c4d3e
- 19,119 shares@ ₹64.490831.3% of flowEquity SharesSEBI:e2b70e86acc2379a62951a7a8b93d14714c2e835
- 27,622 shares@ ₹59.516844.4% of flowEquity SharesSEBI:b43bce0cba0e573a52aafe0a9e84c4f31236ae62
- 10,000 shares@ ₹74.6037.5% of flowEquity SharesSEBI:fcd4dbf25db12fb52bfcf2deceb63e5180261d3a
- 10,600 shares@ ₹70.3437.7% of flowEquity SharesSEBI:a432879d43fb3a515d0cfc4020d43efdca25e20a
- 5,000 shares@ ₹99.8424.8% of flowEquity SharesSEBI:1fd3113c2f96807371d9751a321cd1ad18482681
14 of 14 declarations
About Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is a company engaged in the manufacturing of pharmaceutical products. It is listed on the XBOM market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
